SCHEMBL6017944

SCHEMBL6017944

O=C(N[C@@H](CCCNCc1c[nH]cn1)C(=O)NCc1cccc2ccccc12)c1ccc(CNCc2c[nH]cn2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.47
HDAC3 O15379 2/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC2 Q92769 2/20 0.45
MCHR1 Q99705 5/20 0.42
FOLH1 Q04609 1/20 0.40
PADI4 Q9UM07 3/20 0.40
PADI2 Q9Y2J8 2/20 0.39
KDM1A O60341 5/20 0.39
MAOA P21397 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
TPSAB1 Q15661 1/20 0.39
KDM1B Q8NB78 1/20 0.38
CCKBR P32239 1/20 0.38
NCOR2 Q9Y618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6689563 0.87 FOLH1 (0.45) CXCR4FOLH1PRSS1PRSS2PRSS3
SCHEMBL6018195 0.84 CXCR4 (0.46) CXCR4HDAC3HDAC1HDAC2MCHR1
SCHEMBL6018843 0.83 CXCR4 (0.51) CXCR4HDAC1HDAC2FOLH1PRSS1
SCHEMBL6018099 0.83 CXCR4 (0.46) CXCR4HDAC3HDAC1HDAC2MCHR1
SCHEMBL6018284 0.81 HDAC3 (0.47) CXCR4HDAC3HDAC1HDAC2MCHR1
SCHEMBL6017948 0.80 HDAC1 (0.45) CXCR4HDAC3HDAC1HDAC2MCHR1
SCHEMBL6017964 0.80 CXCR4 (0.43) CXCR4HDAC3HDAC1HDAC2MCHR1
SCHEMBL6018133 0.78 CXCR4 (0.43) CXCR4HDAC3HDAC1HDAC2MCHR1
SCHEMBL6018294 0.78 CXCR4 (0.41) CXCR4HDAC3HDAC1HDAC2MCHR1
SCHEMBL6018022 0.78 CXCR4 (0.41) CXCR4HDAC3HDAC1HDAC2MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7098215-B2 Nitrogenous compounds and antiviral drugs containing the same KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) 2006-08-29 US disclosed
US-20040157818-A1 Cxcr4-antagonistic drugs composed of nitrogen-containing compound KUREHA CORPORATION (JP) 2004-08-12 US disclosed
US-20040092556-A1 Nitrogenous compounds and antiviral drugs containing the same KUREHA CORPORATION (JP) 2004-05-13 US disclosed
EP-1273571-A1 NITROGENOUS COMPOUNDS AND ANTIVIRAL DRUGS CONTAINING THE SAME Kureha Chemical Industry Co., Ltd. (JP) 2003-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092556-A1 Nitrogenous compounds and antiviral drugs containing the same NSUN2, ZC3HAV1L, PNP CXCR4 2185/4885HDAC3 2307/4885HDAC1 651/4885
US-20040157818-A1 Cxcr4-antagonistic drugs composed of nitrogen-containing compound CXCR4, CXCR1, CXCR2 CXCR4 1/4885HDAC3 1135/4885HDAC1 1092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.